I suspect more short sellers as well looking to make a quick buck . Non invasive cgm still a unicorn to serious investors until they can see something tangible. Sp will definitely go up on approval but I suspect more so and with conviction when someone can pick it up off a shelf at a pharma in the UK and actually buy it.
News 
Market Data 
Discover 
